Prognostic and Therapeutic Applications of RKIP in Cancer 2020
DOI: 10.1016/b978-0-12-819612-0.00022-5
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of the Raf kinase inhibitory protein (RKIP) in clear cell renal cell carcinoma associates with poor prognosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 77 publications
0
1
0
Order By: Relevance
“…RKIP has shown promise as a marker in patient tissue studies, as it shows reduced tissue expression following the oncogenic processes from normal kidney tissues to ccRCC and distant metastasis [54,77,78]. However, this trend has also been observed in other urological malignancies, e.g.…”
Section: Raf-kinase Inhibitory Proteinmentioning
confidence: 99%
“…RKIP has shown promise as a marker in patient tissue studies, as it shows reduced tissue expression following the oncogenic processes from normal kidney tissues to ccRCC and distant metastasis [54,77,78]. However, this trend has also been observed in other urological malignancies, e.g.…”
Section: Raf-kinase Inhibitory Proteinmentioning
confidence: 99%